PPP2CB: Protein Phosphatase 2 Catalytic Subunit Beta

A core catalytic subunit of the serine/threonine phosphatase 2A (PP2A) holoenzyme, involved in cell cycle regulation, growth signaling, and tumor suppression.

Gene Information Card

Symbol PPP2CB
Full Name Protein Phosphatase 2 Catalytic Subunit Beta
Gene Type protein-coding
Chromosomal Location 8p12
NCBI Gene ID 5516 ncbi.nlm.nih.gov/gene/5516
Ensembl ID ENSG00000104695
UniProt ID P62714
OMIM ID 176916
HGNC ID 9301
Aliases PP2A-beta, PP2CB, PP2Ac-beta

Description

PPP2CB encodes the beta isoform of the catalytic subunit of protein phosphatase 2A (PP2A), one of the four major serine/threonine phosphatases. PP2A is a heterotrimeric holoenzyme composed of a structural A subunit, a regulatory B subunit, and a catalytic C subunit. The catalytic subunit encoded by PPP2CB is responsible for dephosphorylating key cellular substrates, thereby regulating cell cycle progression, DNA replication, transcription, apoptosis, and signal transduction pathways such as Wnt, PI3K/AKT, and MAPK. PPP2CB is widely expressed and functions as a tumor suppressor; its loss or mutation contributes to oncogenesis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Lung Cancer Reduced PPP2CB expression or activity leads to sustained AKT and ERK signaling, promoting proliferation. COSMIC; PMID: 25691885
Breast Cancer Somatic mutations and copy number loss of PPP2CB impair PP2A tumor suppressor function. ClinVar; COSMIC; PMID: 28481359
Colorectal Cancer PPP2CB downregulation correlates with poor prognosis and increased beta-catenin signaling. NCBI Gene; PMID: 23251476
Prostate Cancer Epigenetic silencing of PPP2CB contributes to PTEN-loss-driven tumorigenesis. OMIM; PMID: 21502521
Intellectual Disability De novo missense variants in PPP2CB are associated with neurodevelopmental delay. ClinVar; PMID: 31036916

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 14.2 Medium
Heart 9.8 Medium
Liver 7.5 Low
Kidney 11.3 Medium
Lung 10.1 Medium
Breast 8.9 Medium
Colon 12.0 Medium
Prostate 9.5 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 12.5 High expression in embryonic kidney cells
HeLa 10.8 Moderate expression in cervical cancer cells
A549 9.2 Lung adenocarcinoma cell line
MCF7 8.7 Breast cancer cell line
HCT116 11.0 Colorectal carcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) missense <0.01% Loss of start codon; likely loss of function
c.287C>T (p.Pro96Leu) missense <0.01% Impaired catalytic activity; associated with intellectual disability
c.511G>A (p.Glu171Lys) missense <0.01% Reduced PP2A activity; found in breast cancer
c.832C>T (p.Arg278Trp) missense <0.01% Decreased substrate dephosphorylation; reported in lung cancer
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Pro96Leu, p.Glu171Lys) reduce catalytic activity or protein stability, impairing PP2A tumor suppressor function.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported for PPP2CB.

Dominant Negative (DN)

Heterozygous mutations (e.g., p.Arg278Trp) may interfere with holoenzyme assembly, acting in a dominant-negative manner.

Pathways

PP2A-mediated dephosphorylation (Reactome: R-HSA-163615)
Signaling by Wnt (Reactome: R-HSA-195721)
PI3K/AKT signaling (KEGG: hsa04151)
MAPK signaling pathway (KEGG: hsa04010)
Cell cycle (KEGG: hsa04110)

Protein Summary

The PPP2CB protein (UniProt P62714) is 309 amino acids long and belongs to the serine/threonine phosphatase family. It forms the catalytic core of the PP2A holoenzyme, which is essential for dephosphorylating a wide range of substrates including AKT, ERK, and beta-catenin. The protein contains a conserved phosphatase domain and is regulated by post-translational modifications such as methylation and phosphorylation. PPP2CB is ubiquitously expressed and its activity is critical for maintaining cellular homeostasis; dysregulation is linked to multiple cancers and neurodevelopmental disorders.

Related Products

Product name Cat.No. Species Gene ID
PPP2CB Knockout HEK293 Cell Line EDJ-KQ1370 Human 5516 Details Get a Quote
PPP2CB Knockout HCT 116 Cell Line EDJ-KQ19523 Human 5516 Details Get a Quote
PPP2CB Knockout A-549 Cell Line EDJ-KQ20867 Human 5516 Details Get a Quote
PPP2CB Knockout HeLa Cell Line EDJ-KQ20868 Human 5516 Details Get a Quote
PPP2CB Knockout HAP1 Cell Line EDC09257 Human 5516 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: